A Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Brincidofovir Administered Intravenously in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 07 Oct 2018
At a glance
- Drugs Brincidofovir (Primary)
- Indications Adenovirus infections; Cytomegalovirus infections; Monkeypox; Smallpox; Viral infections
- Focus Adverse reactions
- Sponsors Chimerix
- 07 Oct 2018 Results presented at the IDWeek 2018
- 05 Oct 2018 According to a Chimerix media release, data from this study will be presented at IDWeek 2018.
- 05 Jan 2018 According to a Chimerix media release, the company expects to provide data in the second half of 2018.